Many cancers express altered mucin-type O-glycans (reviewed in [52]) including glioma where aberrant glycosylation of tumor glycan-rich extracellular matrix promotes tumor progression and treatment resistance [44]. This evidence concerns the gene MUC5AC and glioma.